Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Clinical trial NCT00227019 · COMPLETED

Trial details

NCT number: NCT00227019
Sponsor: Heather Wakelee
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Lung Cancer Neoplasm Metastasis

Start date: 2006-03-01
Primary completion: 2010-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.